195 related articles for article (PubMed ID: 22245203)
1. Radioprotective effect of lidocaine on function and ultrastructure of salivary glands receiving fractionated radiation.
Hakim SG; Benedek GA; Su YX; Jacobsen HC; Klinger M; Dendorfer A; Hemmelmann C; Meller B; Nadrowitz R; Rades D; Sieg P
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e623-30. PubMed ID: 22245203
[TBL] [Abstract][Full Text] [Related]
2. Radioprotective effect of lidocaine on neurotransmitter agonist-induced secretion in irradiated salivary glands.
Su YX; Benedek GA; Sieg P; Liao GQ; Dendorfer A; Meller B; Rades D; Klinger M; Hakim SG
PLoS One; 2013; 8(3):e60256. PubMed ID: 23555936
[TBL] [Abstract][Full Text] [Related]
3. Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.
Bohuslavizki KH; Klutmann S; Brenner W; Kröger S; Buchert R; Bleckmann C; Mester J; Henze E; Clausen M
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():6-12. PubMed ID: 10584133
[TBL] [Abstract][Full Text] [Related]
4. A comparative study on the protection profile of lidocaine, amifostine, and pilocarpin on the parotid gland during radiotherapy.
Hakim SG; Kosmehl H; Lauer I; Nadrowitz R; Wedel T; Sieg P
Cancer Res; 2005 Nov; 65(22):10486-93. PubMed ID: 16288041
[TBL] [Abstract][Full Text] [Related]
5. [Histomorphologic and salivary gland scintigraphic findings in radiation-induced sialadenitis due to fractionated irradiation of the head and neck region of rats. A model for evaluating potentially radioprotective substances].
Sagowski C; Wenzel S; Riehle I; Tesche S; Jenicke L; Zywietz F; Roeser K; Metternich FU
HNO; 2004 Jan; 52(1):25-32. PubMed ID: 14740111
[TBL] [Abstract][Full Text] [Related]
6. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
[TBL] [Abstract][Full Text] [Related]
7. TAT-mediated delivery of Tousled protein to salivary glands protects against radiation-induced hypofunction.
Sunavala-Dossabhoy G; Palaniyandi S; Richardson C; De Benedetti A; Schrott L; Caldito G
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):257-65. PubMed ID: 22285666
[TBL] [Abstract][Full Text] [Related]
8. In regard to Münter et Al. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without amifostine. (Int j radiat oncol biol phys 2007;67:651-659).
Messerschmidt GL; Oleka N
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1651-2; author reply 1652. PubMed ID: 18035221
[No Abstract] [Full Text] [Related]
9. Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy.
Dirix P; De Keyzer F; Vandecaveye V; Stroobants S; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1365-71. PubMed ID: 18355977
[TBL] [Abstract][Full Text] [Related]
10. The role of myoepithelial cells in the short-term radiogenic impairment of salivary glands. An immunohistochemical, ultrastructural and scintigraphic study.
Hakim SG; Kosmehl H; Lauer I; Nadrowitz R; Wedel T; Sieg P
Anticancer Res; 2002; 22(6C):4121-8. PubMed ID: 12553042
[TBL] [Abstract][Full Text] [Related]
11. In regards to Münter et Al. (Int J Radiat Oncol Biol Phys 2007;67:651-659).
Samuels MA
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):318; author reply 318-9. PubMed ID: 17707287
[No Abstract] [Full Text] [Related]
12. Salivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (amifostine) in high-dose radioiodine treatment: results obtained in a rabbit animal model and in a double-blind multi-arm trial.
Bohuslavizki KH; Klutmann S; Jenicke L; Kröger S; Buchert R; Mester J; Clausen M
Cancer Biother Radiopharm; 1999 Oct; 14(5):337-47. PubMed ID: 10850318
[TBL] [Abstract][Full Text] [Related]
13. [Normal tissue tolerance to external beam radiation therapy: salivary glands].
Ortholan C; Benezery K; Bensadoun RJ
Cancer Radiother; 2010 Jul; 14(4-5):290-4. PubMed ID: 20609609
[TBL] [Abstract][Full Text] [Related]
14. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of salivary gland function in lymphoma patients receiving head and neck irradiation.
Rodrigues NA; Killion L; Hickey G; Silver B; Martin C; Stevenson MA; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1079-83. PubMed ID: 19327910
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of tempol for prevention of xerostomia following head and neck irradiation in a mouse model.
Cotrim AP; Sowers AL; Lodde BM; Vitolo JM; Kingman A; Russo A; Mitchell JB; Baum BJ
Clin Cancer Res; 2005 Oct; 11(20):7564-8. PubMed ID: 16243832
[TBL] [Abstract][Full Text] [Related]
17. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642
[TBL] [Abstract][Full Text] [Related]
18. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E protects salivary glands dysfunction induced by ionizing radiation in rats.
Abedi SM; Yarmand F; Motallebnejad M; Seyedmajidi M; Moslemi D; Ashrafpour M; Bijani A; Moghadamnia A; Mardanshahi A; Hosseinimehr SJ
Arch Oral Biol; 2015 Sep; 60(9):1403-9. PubMed ID: 26150230
[TBL] [Abstract][Full Text] [Related]
20. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
